HIGHFDA DRUG

Baxter Acetaminophen Injection 1000 mg/100 mL Recall for Discoloration

Baxter Healthcare’s Acetaminophen Injection 1000 mg/100 mL is recalled. The nationwide recall covers 13,000 containers with lot 24A27G66 and expiring 12/31/2025. The FDA lists discoloration as the hazard. Stop using and contact Baxter or a healthcare provider.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 20, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 20, 2025
Hazard Level
HIGH
Brands
Baxter Healthcare Corporation, Acetaminophen
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Baxter Healthcare Corporation, Acetaminophen
Product type
Acetaminophen Injection
Model numbers
Lot #: 24A27G66, Exp 12/31/2025
UPC codes
36000-306, 36000-372, 36000-306-60, 36000-372-40
Sizes
100 mL
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 20, 2025

  2. Reported by FDA DRUG

    September 3, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Discoloration

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Baxter Healthcare Corporation or your healthcare provider for guidance. Notification method: Letter

About This Product

Acetaminophen injections are used in clinical settings for pain management and fever control when oral administration is not possible.

Why This Is Dangerous

Discoloration indicates potential chemical or integrity issues that could affect safety or efficacy.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Health care settings may face workflow disruptions and the need to substitute alternate analgesics.

Practical Guidance

How to identify if yours is affected

  1. Verify container is 100 mL Viaflo
  2. Inspect Lot 24A27G66 and Exp 12/31/2025

Where to find product info

NDC on label, packaging, and accompanying documentation.

What timeline to expect

Refunds/replacements follow Baxter's recall process, typically weeks to months depending on caseload.

If the manufacturer is unresponsive

  • Escalate to FDA recall contacts
  • File a complaint with the FDA if needed

How to prevent similar issues

  • Verify NDC and lot numbers before use
  • Keep recall communication and letters for records
  • Consult pharmacist before substituting medications

Documentation advice

Document recall notice, lot number, expiration, and correspondence with Baxter.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Acetaminophen Injection 1000 mg/100 mL. Container: Viaflo 100 mL. Route: Rx only. Manufacturer: Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 36000-306-60. Quantity: 13,000 containers. Distribution: U.S. nationwide. Lot: 24A27G66. Expiry: 12/31/2025.

Reported Incidents

No specific injuries or incidents are described in the provided recall data.

Key Facts

  • Lot 24A27G66
  • Distribution nationwide in the USA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANT
Injury Types
POISONINGOTHER

Product Details

Model Numbers
Lot #: 24A27G66
Exp 12/31/2025
UPC Codes
36000-306
36000-372
36000-306-60
+1 more
Affected States
ALL
Report Date
September 3, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more